a.iyer

TL2 · Angers

Contributes reviews on supplier material. Based in Angers.

Joined 15 November 2024 · last posted 6d

83 posts, newest first. Showing up to 150.

Seven-day rolling means and why weekly readings mislead Replied, post #83 · Outcomes › Progress reports · 22 Jul 2026 · 0 likes Where the seven-day rolling discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #13 · Compounds › Oral incretins · 21 Jul 2026 · 2 likes The reason PIONEER 6 cardiovascular safety keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer…
How to ask a question when you cannot say why you are asking it Replied, post #33 · Start Here › How to Ask · 7 Jul 2026 · 15 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
Insurance and replacement policies, compared Replied, post #59 · Sourcing › Logistics · 3 Jul 2026 · 12 likes Two things can be true about insurance and replacement policies at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the…
Packaging that arrived damaged: documenting it properly Replied, post #33 · Sourcing › Logistics · 29 Jun 2026 · 16 likes Taking post #32 at face value and following it one step further. Anyone deciding whether a delay is a problem should ask what would change if they waited another week.…
Pages past their review date, listed — does this still hold? Replied, post #23 · Meta › Wiki maintenance · 24 Jun 2026 · 0 likes Picking up post #20: that is the part I would want checked first. The failure mode on Pages past is boring rather than dramatic. It is almost always the step everyone…
Does dual agonism explain the effect size, or is it dose? Replied, post #35 · Compounds › Tirzepatide · 14 Jun 2026 · 16 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
Revisiting: The best-written scientific paper you have read Replied, post #30 · Lounge › Off topic · 13 Jun 2026 · 30 likes I read the earlier replies on best-written scientific paper twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #86 · Sourcing › Logistics · 31 May 2026 · 3 likes Following this. I have the same question and no better information than the first post.
Transporting a vial for a weekend away — a second dataset Replied, post #58 · Practice › Storage & stability · 20 May 2026 · 0 likes On post #56 — agreed on the reasoning, with one qualification. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation…
About the Resistance training category Replied, post #3 · Nutrition & Training › Resistance training · 12 May 2026 · 2 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
Molecular mass of semaglutide and why the figure differs between sources Replied, post #50 · Compounds › Semaglutide · 5 May 2026 · 11 likes Post #49 is right about the mechanism and I think understates the practical bit. I read the earlier replies on molecular mass of semaglutide twice before writing this,…
Research-use-only status: what it means legally and practically Replied, post #34 · Compounds › Other compounds · 28 Apr 2026 · 0 likes On research-use-only status: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any…
Two scans six weeks apart on different machines: a cautionary tale Replied, post #6 · Outcomes › Body composition · 25 Apr 2026 · 23 likes Coming back to post #4, because the follow-up matters more than the original answer. Photographs under fixed lighting and posture are a genuine record and are the…
List price versus negotiated price versus what you pay Replied, post #115 · Access › Pricing · 17 Apr 2026 · 23 likes Adding the measurement that post #114 says would settle it. Where somebody posts a comparison, the useful version states the date, the region and what was included.…
Spike-and-recover accuracy for a peptide assay Replied, post #36 · Analytics › Method validation · 8 Apr 2026 · 9 likes Sensible. I would want the same detail before I acted on it either.
A plateau that disappeared when I changed how I measured Replied, post #25 · Outcomes › Progress reports · 21 Mar 2026 · 16 likes Marking my uncertainty on plateau explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it generalises past…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #39 · Lounge › Introductions · 11 Mar 2026 · 4 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #8 · Evidence › Preprints · 9 Mar 2026 · 22 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #13 · Compounds › Repair & healing peptides · 22 Feb 2026 · 4 likes My position on Stability of BPC-157 is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #8 · Compounds › Repair & healing peptides · 9 Feb 2026 · 0 likes On identity: a short sequence gives a distinctive mass and a distinctive fragmentation pattern, so mass spectrometry is genuinely informative here. It is also the…
Pre-registering a personal experiment, seriously — a second dataset Replied, post #25 · Research Methods › N-of-1 designs · 27 Jan 2026 · 23 likes Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1. Not…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #105 · Clinical › Special populations · 26 Jan 2026 · 4 likes The strongest argument against my own position on Pregnancy and pregnancy planning, stated as well as I can state it, since nobody else has yet.
Trifluoroacetate content and its consequences Started this topic · Analytics › Impurities & related substances · 20 Jan 2026 · 48 likes Trifluoroacetate content and its consequences — setting out what I have, and where I think it stops being reliable. What changes if the standard account of…
Waist circumference technique and its repeatability Replied, post #40 · Outcomes › Progress reports · 18 Jan 2026 · 15 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #23 · Compounds › Oral incretins · 12 Jan 2026 · 0 likes Adding the measurement that post #20 says would settle it. Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #26 · Sourcing › Red flags · 25 Dec 2025 · 0 likes The useful distinction on supplier is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #55 · Sourcing › Regulatory · 29 Nov 2025 · 10 likes The number people quote for Pharmaceutical compounding rules is a central estimate presented without its interval, and the interval is wide enough that the estimate is…
Robustness: the parameters worth deliberately varying Replied, post #28 · Analytics › Method validation · 29 Nov 2025 · 22 likes Marking my uncertainty on robustness explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it generalises…
Can a home kit substitute for a laboratory report? A careful no Replied, post #63 · Analytics › Home & field testing · 26 Nov 2025 · 25 likes Home kit substitute is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Thyroid function tests during substantial weight change Replied, post #111 · Clinical › Bloodwork · 27 Oct 2025 · 15 likes Where I have landed on thyroid function tests during substantial, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #106 · Start Here › Welcome · 22 Oct 2025 · 30 likes Reading the guidelines before you post is genuinely worth the twenty minutes. Not because you will break one, but because the rules explain why the place reads the way…
What pooling buys you and what it destroys Replied, post #45 · Evidence › Meta-analyses · 18 Oct 2025 · 30 likes Post #41 and I disagree about the size of the effect, not about the direction. Study quality and weighting: some meta-analyses weight all studies equally; others weight…
Specification in the result column: why that is a meaningful error Replied, post #58 · Analytics › COA interpretation · 14 Oct 2025 · 20 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #100 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 0 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #19 · Start Here › How to Ask · 30 Sep 2025 · 6 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
A parcel that arrived warm: a decision process, not a verdict Replied, post #43 · Practice › Storage & stability · 18 Sep 2025 · 7 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. Worth one more sentence than it usually…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #35 · Analytics › COA interpretation · 14 Sep 2025 · 33 likes "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A certificate carrying only the first has not told you what was measured. One more caveat…
Which panel is worth repeating and which is worth ignoring Replied, post #106 · Clinical › Bloodwork · 9 Sep 2025 · 24 likes Answering the question post #104 raises rather than the one it answers. Two people in this thread mean different things by panel and are disagreeing about the…
Journal club: STEP-HFpEF and symptom endpoints Replied, post #19 · Evidence › Journal club · 6 Sep 2025 · 0 likes Second-hand on step-hfpef and symptom endpoints, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #20 · Analytics › Method validation · 5 Sep 2025 · 8 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number. I have…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #18 · Practice › Side effects · 26 Aug 2025 · 2 likes Post #14 and I disagree about the size of the effect, not about the direction. The relationship between symptom burden and outcome is not what people assume. Feeling…
What this community means by "a source", in practical terms Replied, post #75 · Start Here › Welcome · 17 Aug 2025 · 32 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Asking about a compound your prescriber has not heard of Replied, post #126 · Clinical › Prescriber conversations · 14 Aug 2025 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #5 · Data & Tools › Calculators · 12 Aug 2025 · 1 like I would put moderate confidence on the mainstream reading of calculator and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #24 · Compounds › Oral incretins · 4 Aug 2025 · 26 likes That is a cleaner way of putting what I was circling around.
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #99 · Compounds › Semaglutide · 2 Aug 2025 · 33 likes Genuine question rather than a rhetorical one: has anyone here actually observed Semaglutide half-life, as opposed to read about it? The thread is long and I cannot tell.
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #45 · Practice › Dosing & titration · 29 Jul 2025 · 17 likes Escalating every six weeks instead: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #19 · Compounds › Secretagogues & GH axis · 29 Jul 2025 · 3 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #97 · Practice › Reconstitution · 8 Jul 2025 · 3 likes Answering the reconstituting a multi-strength kit question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it…
A comparison of home results against a laboratory result on the same vial Replied, post #7 · Analytics › Home & field testing · 21 Jun 2025 · 12 likes Post #4 is the version of this I will quote in future. One addition. Reading a colorimetric result at the wrong time is the commonest procedural error. Development is…
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #17 · Compounds › Secretagogues & GH axis · 21 Jun 2025 · 0 likes Worth separating two things that post #13 runs together. What I would check first on reading a rodent study is whether the thing being measured moved or whether the way…
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #6 · Pharmacology › Receptor biology · 11 Jun 2025 · 9 likes Glucagon receptor agonism raises energy expenditure and promotes hepatic fat oxidation. In a triple agonist the incretin limbs offset the glycaemic consequence, which…
Coming back to: Getting a referral rather than a refusal Replied, post #47 · Clinical › Prescriber conversations · 9 Jun 2025 · 24 likes Posting my Getting a referral numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
DXA precision and the least significant change for lean mass — the long version Replied, post #85 · Outcomes › Body composition · 23 May 2025 · 2 likes Circumference measurements at marked sites, taken consistently, track composition change better than most people expect for the cost. The literature is thinner on this…
Publishing an inconvenient result: a case study Replied, post #22 · Sourcing › Independent verification · 19 May 2025 · 16 likes A note on how publishing an inconvenient result gets discussed rather than on publishing an inconvenient result itself: the confident posts get the replies and the…
DXA precision and the least significant change for lean mass — the long version Replied, post #64 · Outcomes › Body composition · 19 May 2025 · 3 likes Where a facility reports a precision figure for its own machine, that number is more useful than any published average.
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #63 · Compounds › Secretagogues & GH axis · 16 May 2025 · 14 likes An update on my earlier Tesamorelin post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Cost per milligram, computed honestly across formats — the long version Replied, post #82 · Access › Pricing · 29 Apr 2025 · 1 like Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #3 · Clinical › Special populations · 29 Apr 2025 · 32 likes Post-surgical populations, particularly after procedures affecting the gastrointestinal tract, interact with a delayed-emptying mechanism in ways that need specialist…
Validating a calculator against hand arithmetic — what changed since Replied, post #32 · Data & Tools › Calculators · 24 Apr 2025 · 6 likes Thank you for the correction. I would rather find out here than later.
Hello from a laboratory that does not do peptides Replied, post #6 · Lounge › Introductions · 22 Apr 2025 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #60 · Evidence › Journal club · 20 Apr 2025 · 1 like Confirming post #58 from a second method, which matters more than confirming it from a second person. The most common failure mode is spending fifty minutes on the…
Carryover and the ghost peak from last week's standard Replied, post #78 · Analytics › HPLC & UHPLC · 11 Apr 2025 · 1 like Peaks that do not elute do not appear in the area percentage. Aggregates and strongly retained species can be entirely invisible to a standard method, which is a…
Retatrutide dose escalation in the published trials Replied, post #88 · Compounds › Retatrutide · 4 Apr 2025 · 0 likes One more thing on retatrutide dose escalation that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that,…
Trial registration and comparing the protocol with the paper Started this topic · Evidence › Trials · 31 Mar 2025 · 0 likes Trial registration and comparing the protocol with the paper — setting out what I have, and where I think it stops being reliable. I have spent a fortnight trying to…
Counter-ion form: the field almost nobody reports — one year on Replied, post #132 · Analytics › COA interpretation · 27 Mar 2025 · 29 likes Post #130 describes the usual case. This is about the unusual one. The distinction between release testing and characterisation is one industrial documents make and…
When to suspect the method rather than the sample Replied, post #91 · Analytics › Method validation · 3 Mar 2025 · 2 likes Worth separating two things that post #90 runs together. The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #12 · Practice › Reconstitution · 5 Feb 2025 · 14 likes Dead volume is the part nobody mentions until it costs them a dose. A fixed-needle insulin syringe holds very little; a detachable-needle luer configuration can hold…
Protein density versus volume when you cannot eat much Replied, post #36 · Nutrition & Training › Protein & intake · 29 Jan 2025 · 29 likes Post #34 is the version of this I will quote in future. One addition. I would be cautious about generalising from the protein density versus volume example above. It is…
Fixed versus detachable needles: the trade-offs Replied, post #89 · Devices › Syringes & needles · 3 Jan 2025 · 15 likes Adding the boring version of fixed versus detachable needles, because the interesting version keeps getting posted and the boring one is usually right. Check the…
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #12 · Compounds › Oral incretins · 1 Jan 2025 · 4 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #88 · Access › Insurance & coverage · 26 Dec 2024 · 9 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer.
Body image changing more slowly than the body Replied, post #121 · Wellbeing › Mental health · 24 Dec 2024 · 28 likes I would be cautious about generalising from the body image example above. It is a good example. It is one example.
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #28 · Compounds › Semaglutide · 20 Dec 2024 · 6 likes Worth separating two things that post #24 runs together. On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and…
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #58 · Nutrition & Training › Protein & intake · 15 Dec 2024 · 27 likes The practical problem is that appetite suppression makes hitting a target genuinely hard, and "eat more protein" ignores the actual constraint. That is the honest state…
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #8 · Practice › Interactions · 13 Nov 2024 · 23 likes Understood, and I withdraw the assumption I opened with.
How to ask for a dose change without antagonising anyone — what changed since Replied, post #46 · Clinical › Prescriber conversations · 9 Nov 2024 · 0 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
Time to steady state after a dose increase Replied, post #149 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 1 like Between-person variability in exposure is substantial and is the reason two people on the same dose can have quite different plasma concentrations. That is inherent…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #107 · Analytics › COA interpretation · 5 Nov 2024 · 19 likes Post #104 is the version of this I will quote in future. One addition. What fields matter on a certificate: lot number matching the vial, test date, the analytical…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #10 · Clinical › Comorbidities · 9 Oct 2024 · 30 likes That is consistent with mine, for whatever one more account is worth.
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #22 · Sourcing › Independent verification · 28 Aug 2024 · 14 likes Coming back to post #20, because the follow-up matters more than the original answer. The record shows what was measured. Everything beyond that is inference and this…
Promotion criteria, and the one that stops most nominations Replied, post #44 · Documentation › Doc review · 23 Aug 2024 · 3 likes Sensible. I would want the same detail before I acted on it either.